rood blauwe elepsis logo Belegger.nl

Corus Terug naar discussie overzicht

Major shareholders per november 2006

3 Posts
| Omlaag ↓
  1. k.bruin 24 november 2006 20:14
    Major shareholders
    At November 2006, Corus Group had been notified of the following substantial shareholdings in its issued ordinary share capital:

    Standard Life Investments 7.81%
    UBS AG 7.36%
    Barclays plc 4.70%
    Goldman Sachs 4.01%
    Legal & General Investment Mgt 3.82%
    Supernova Acquisitions 3.80%
    Lehman Brothers 3.45%
    Capital Group 3.05%

    De posities worden ingenomen in het gevecht rondom Corus. CSN heeft al aardig wat stukken binnengehaald. Nu het officiele bod nog.
  2. [verwijderd] 27 november 2006 10:36
    The Board of Corus has decided that it is in the best interests of Corus
    Shareholders to allow CSN some additional time to satisfy its pre-conditions and
    to determine whether it will put forward a formal offer.

    Dus; Van de drie eisen die CSN heeft is er al 1 voldaan. Men wil namelijk een poitief advies van de raad van bestuur. Dat de board meent dat het in the best interests of corus shareholders is, zegt genoeg op dat punt.

    At this time, the Panel on Takeovers and Mergers (the "Panel") has not set a
    date by which CSN is required to clarify its intentions and either announce a
    formal offer for Corus or confirm its intention not to do so. In the event that
    the Panel subsequently sets such a deadline, an appropriate announcement will be
    made.

    Dus; Het leidende overname team stelt geen momenteel geen harde deadline aan CSN om een bod uit te brengen. Mocht die deadline er komen worden we daarvan op de hoogte gebracht.

    Bron van engelste tekst;
    BETTEN BEURSMEDIA NEWS
  3. k.bruin 6 december 2006 18:12
    Standard Life Investments 7.81%
    UBS AG 7.36%
    Barclays plc 4.70%
    Goldman Sachs 4.01%
    Legal & General Investment Mgt 3.82%
    Supernova Acquisitions 3.80%
    Lehman Brothers 3.45%
    Capital Group 3.05%

    Toegevoegd:

    Melding via regulatory news op 6-12:

    Merrill Lynch 6,13 %

    Totaal 44,13 % bij institutionele beleggers.
3 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.017
AB InBev 2 5.496
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.649
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.645
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.751
Aedifica 3 916
Aegon 3.258 322.826
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.892
Agfa-Gevaert 14 2.050
Ahold 3.538 74.335
Air France - KLM 1.025 35.043
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.804
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.162
AMG 971 133.325
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.998
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.776
Arcelor Mittal 2.033 320.706
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.300
Aroundtown SA 1 219
Arrowhead Research 5 9.737
Ascencio 1 27
ASIT biotech 2 697
ASMI 4.108 39.096
ASML 1.766 107.172
ASR Nederland 21 4.484
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.667
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392